Clinical Trials
19
Active:9
Completed:8
Trial Phases
3 Phases
Phase 1:10
Phase 2:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Phase 1
10 (76.9%)Phase 2
2 (15.4%)Not Applicable
1 (7.7%)A Drug-Drug Interaction Study to Evaluate the Effect of Vapendavir on the Pharmacokinetics of Midazolam in Healthy Male and Female Volunteers
Phase 1
Completed
- Conditions
- Drug-Drug Interaction Healthy Volunteers
- Interventions
- First Posted Date
- 2014-07-30
- Last Posted Date
- 2018-05-30
- Lead Sponsor
- Biota Scientific Management Pty Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT02204501
- Locations
- 🇺🇸
Prism Clinical Research, Saint Paul, Minnesota, United States
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma
- First Posted Date
- 2013-12-30
- Last Posted Date
- 2018-05-30
- Lead Sponsor
- Biota Scientific Management Pty Ltd
- Target Recruit Count
- 32
- Registration Number
- NCT02022761
- Locations
- 🇬🇧
Respiratory Clinical Trials, London, United Kingdom
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza
Phase 1
Terminated
- Conditions
- Influenza
- Interventions
- First Posted Date
- 2013-12-18
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Biota Scientific Management Pty Ltd
- Target Recruit Count
- 15
- Registration Number
- NCT02014649
- Locations
- 🇺🇸
Precision Trials LLC, Phoenix, Arizona, United States
🇺🇸Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸SoCal Clinical Research Med Group, Bellflower, California, United States
Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza
Phase 2
Completed
- Conditions
- Influenza
- Interventions
- First Posted Date
- 2013-02-18
- Last Posted Date
- 2018-05-31
- Lead Sponsor
- Biota Scientific Management Pty Ltd
- Target Recruit Count
- 639
- Registration Number
- NCT01793883
- Locations
- 🇺🇸
Scottsboro Quick Care Clinic, Scottsboro, Alabama, United States
🇺🇸Clinical Trial Connection, Camp Verde, Arizona, United States
🇺🇸Warner Family Practice, Chandler, Arizona, United States
A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
- First Posted Date
- 2010-08-04
- Last Posted Date
- 2018-05-31
- Lead Sponsor
- Biota Scientific Management Pty Ltd
- Target Recruit Count
- 300
- Registration Number
- NCT01175226
- Locations
- 🇺🇸
Research Site, West Allis, Wisconsin, United States
- Prev
- 1
- 2
- Next
News
No news found